Before We Start
The diagnostic threshold, and why it matters clinically
Major depressive disorder (MDD) is diagnosed when a patient experiences 5 or more of the SIGECAPS symptoms, present for 2 or more weeks. This isn't just an academic diagnostic threshold — understanding the full symptom cluster helps a nurse recognize depression even when a patient doesn't explicitly say "I feel depressed," since some of these symptoms (sleep changes, appetite changes, concentration difficulty) can be the most visible clues.
💡 The Counterintuitive Safety Fact at the Heart of This Lesson
Suicide risk is highest not at the depth of depression, but during early recovery — specifically when antidepressants begin working. The reasoning: energy and motivation often return before mood fully lifts, meaning a patient who previously lacked the energy to act on suicidal thoughts may now have just enough energy to act on a plan they've been carrying, while their mood hasn't yet caught up.
Mnemonic
SIGECAPS — the eight diagnostic symptoms
S — Sleep Changes
Insomnia or hypersomnia
Either significantly reduced sleep or excessive sleep can indicate depression — the direction of change varies between patients.
I — Interest Loss
Anhedonia
Loss of interest or pleasure in activities that were previously enjoyable — one of the two core diagnostic symptoms of MDD (alongside depressed mood itself).
G — Guilt/Worthlessness
Excessive or inappropriate guilt
Feelings of worthlessness or guilt that are disproportionate to actual circumstances.
E — Energy Loss
Fatigue
Persistent low energy or fatigue, even without significant physical exertion.
C — Concentration Impairment
Difficulty thinking or making decisions
Reduced ability to concentrate, think clearly, or make decisions — sometimes mistaken for a cognitive or memory problem rather than a symptom of depression itself.
A — Appetite/Weight Changes
Either direction
Significant weight loss or gain, or decreased or increased appetite — similar to sleep changes, the direction varies between individuals.
P — Psychomotor Changes
Agitation or retardation
Either visibly slowed movements and speech (psychomotor retardation) or visible restlessness and agitation can occur.
S — Suicidal Ideation
Thoughts of death or suicide
Recurrent thoughts of death, suicidal ideation with or without a specific plan — see the dedicated SAL lesson for the full risk assessment framework once this symptom is present.
💊 5 or more of these 8 symptoms, present for 2 or more weeks, meets the diagnostic threshold for major depressive disorder.
Treatment and Safety
Medication timeline and the critical monitoring window
SSRI Timeline
2-6 weeks for full effect
Patients need to be educated that SSRIs are not immediate — full therapeutic effect typically takes 2 to 6 weeks, and this needs to be clearly communicated so patients don't stop the medication prematurely, believing it "isn't working."
The High-Risk Window
Close monitoring in the first 2-4 weeks of treatment
Because energy often returns before mood fully lifts, the first 2-4 weeks after starting or adjusting an antidepressant is a period requiring especially close monitoring for suicidal ideation — this is precisely when risk is highest, not when the patient is at their most severely depressed.
Black Box Warning
Increased suicidality risk in patients under 25
SSRIs carry an FDA black box warning specifically for increased suicidality risk in patients under 25 years old — this population requires even closer monitoring during the early treatment window.
ECT
Electroconvulsive therapy — effective, not punitive
ECT is a legitimate, effective treatment for severe depression (particularly treatment-resistant cases), not a punishment or outdated practice as sometimes portrayed — patient and family education addressing stigma around ECT is a genuine part of nursing care when it's part of the treatment plan.
🏥 Clinical Scenario — Recognizing the High-Risk Recovery Window
A patient started on an SSRI three weeks ago for severe depression now appears more energetic and is up and moving around more than they were at admission. A new nurse notes this as a positive sign and considers reducing the frequency of safety checks.
Recognize the Risk
Increased energy at the 3-week mark, while mood may not have fully lifted yet, places this patient squarely in the highest-risk window for suicide — not a signal that safety monitoring can be relaxed. This is exactly the counterintuitive pattern that makes this window so dangerous: the improvement itself is what enables risk, rather than reducing it.
Correct the Assumption
Rather than reducing safety checks, the nurse maintains or even increases monitoring frequency during this specific window, and reassesses suicidal ideation directly rather than assuming improved energy equals improved safety. Visible improvement in energy is not the same as resolved risk — these need to be assessed separately.
📌 NCLEX Application
SIGECAPS and depression questions frequently test the counterintuitive risk-timing concept directly:
Risk timing: "At what point during antidepressant treatment is suicide risk considered highest?" → During early recovery, when energy returns before mood fully lifts — not at the point of most severe depression.
Diagnostic threshold: "How many SIGECAPS symptoms, and for how long, are required for a diagnosis of major depressive disorder?" → 5 or more symptoms, present for 2 or more weeks.
Medication education: "A patient starting an SSRI asks when they should expect to feel better. What should the nurse explain?" → Full effect typically takes 2 to 6 weeks — the medication is not immediate.
⚠️ The Trap — Assuming Visible Improvement Means Reduced Suicide Risk
It's intuitive to assume that a patient who appears more energetic and active is doing better across the board, including in terms of suicide risk. But this is exactly backward during the early recovery window — increased energy without a corresponding lift in mood can provide the physical capacity to act on suicidal thoughts that were previously present but unactionable due to low energy.
The safeguard: Treat the first 2-4 weeks of antidepressant treatment as a distinct, high-vigilance period regardless of how much the patient's energy or activity level appears to have improved — reassess suicidal ideation directly rather than inferring safety from energy alone.
✓ Quick Self-Test
Answer before checking:
1. What does each letter in SIGECAPS stand for?
2. How many symptoms, for how long, are needed to diagnose MDD?
3. Why is suicide risk highest during early recovery rather than at the depth of depression?
4. Which patient population carries a specific FDA black box warning for SSRIs?
Answers:
1. Sleep, Interest loss, Guilt, Energy loss, Concentration impairment, Appetite/weight changes, Psychomotor changes, Suicidal ideation.
2. 5 or more symptoms, present for 2 or more weeks.
3. Because energy and motivation often return before mood fully lifts, giving a patient renewed capacity to act on suicidal thoughts that were previously present but unactionable due to low energy.
4. Patients under 25 years old.
Next Lesson
DIGFAST — Recognizing Mania
→